nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemcitabine—RRM2—Hydroxyurea—psoriasis	0.292	0.399	CbGbCtD
Gemcitabine—RRM1—Hydroxyurea—psoriasis	0.292	0.399	CbGbCtD
Gemcitabine—ABCC10—Cyclosporine—psoriasis	0.051	0.0697	CbGbCtD
Gemcitabine—TYMS—Methotrexate—psoriasis	0.0327	0.0447	CbGbCtD
Gemcitabine—ABCC10—Methotrexate—psoriasis	0.027	0.0369	CbGbCtD
Gemcitabine—ABCB1—Mycophenolate mofetil—psoriasis	0.00627	0.00856	CbGbCtD
Gemcitabine—ABCB1—Betamethasone—psoriasis	0.00538	0.00735	CbGbCtD
Gemcitabine—ABCB1—Prednisolone—psoriasis	0.00531	0.00725	CbGbCtD
Gemcitabine—ABCB1—Hydrocortisone—psoriasis	0.00503	0.00687	CbGbCtD
Gemcitabine—ABCB1—Prednisone—psoriasis	0.00501	0.00685	CbGbCtD
Gemcitabine—ABCB1—Cyclosporine—psoriasis	0.00475	0.00649	CbGbCtD
Gemcitabine—ABCB1—Dexamethasone—psoriasis	0.00313	0.00427	CbGbCtD
Gemcitabine—ABCB1—Methotrexate—psoriasis	0.00251	0.00343	CbGbCtD
Gemcitabine—POLD1—Mismatch repair—PCNA—psoriasis	0.00183	0.0277	CbGpPWpGaD
Gemcitabine—POLD1—Removal of the Flap Intermediate from the C-strand—PCNA—psoriasis	0.00169	0.0255	CbGpPWpGaD
Gemcitabine—POLD1—Processive synthesis on the C-strand of the telomere—PCNA—psoriasis	0.00146	0.022	CbGpPWpGaD
Gemcitabine—POLD1—Removal of the Flap Intermediate—PCNA—psoriasis	0.00129	0.0195	CbGpPWpGaD
Gemcitabine—POLD1—Leading Strand Synthesis—PCNA—psoriasis	0.00129	0.0195	CbGpPWpGaD
Gemcitabine—POLD1—Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)—PCNA—psoriasis	0.00122	0.0184	CbGpPWpGaD
Gemcitabine—POLD1—Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)—PCNA—psoriasis	0.00122	0.0184	CbGpPWpGaD
Gemcitabine—POLD1—Repair synthesis for gap-filling by DNA polymerase in TC-NER—PCNA—psoriasis	0.00122	0.0184	CbGpPWpGaD
Gemcitabine—POLE—Repair synthesis for gap-filling by DNA polymerase in TC-NER—PCNA—psoriasis	0.00118	0.0178	CbGpPWpGaD
Gemcitabine—POLD1—Processive synthesis on the lagging strand—PCNA—psoriasis	0.00116	0.0175	CbGpPWpGaD
Gemcitabine—POLD1—MMR—PCNA—psoriasis	0.00116	0.0175	CbGpPWpGaD
Gemcitabine—RRM2—G1/S-Specific Transcription—PCNA—psoriasis	0.00111	0.0168	CbGpPWpGaD
Gemcitabine—POLD1—Gap-filling DNA repair synthesis and ligation in GG-NER—PCNA—psoriasis	0.0011	0.0167	CbGpPWpGaD
Gemcitabine—POLD1—Removal of DNA patch containing abasic residue—PCNA—psoriasis	0.0011	0.0167	CbGpPWpGaD
Gemcitabine—POLE—Gap-filling DNA repair synthesis and ligation in GG-NER—PCNA—psoriasis	0.00107	0.0161	CbGpPWpGaD
Gemcitabine—POLD1—Base Excision Repair—PCNA—psoriasis	0.00101	0.0153	CbGpPWpGaD
Gemcitabine—CMPK1—Nucleotide metabolism—CAT—psoriasis	0.000987	0.0149	CbGpPWpGaD
Gemcitabine—POLD1—Lagging Strand Synthesis—PCNA—psoriasis	0.000932	0.0141	CbGpPWpGaD
Gemcitabine—POLA1—Removal of the Flap Intermediate—PCNA—psoriasis	0.000887	0.0134	CbGpPWpGaD
Gemcitabine—POLA1—Leading Strand Synthesis—PCNA—psoriasis	0.000887	0.0134	CbGpPWpGaD
Gemcitabine—POLD1—Telomere C-strand (Lagging Strand) Synthesis—PCNA—psoriasis	0.000866	0.0131	CbGpPWpGaD
Gemcitabine—POLE—Telomere C-strand (Lagging Strand) Synthesis—PCNA—psoriasis	0.000837	0.0127	CbGpPWpGaD
Gemcitabine—POLA1—Processive synthesis on the lagging strand—PCNA—psoriasis	0.000797	0.0121	CbGpPWpGaD
Gemcitabine—POLA1—G1/S-Specific Transcription—PCNA—psoriasis	0.000759	0.0115	CbGpPWpGaD
Gemcitabine—POLD1—skin of body—psoriasis	0.000751	0.127	CbGeAlD
Gemcitabine—TYMS—G1/S-Specific Transcription—PCNA—psoriasis	0.000727	0.011	CbGpPWpGaD
Gemcitabine—POLD1—Extension of Telomeres—PCNA—psoriasis	0.00072	0.0109	CbGpPWpGaD
Gemcitabine—DCK—Purine metabolism—CAT—psoriasis	0.000708	0.0107	CbGpPWpGaD
Gemcitabine—POLE—Extension of Telomeres—PCNA—psoriasis	0.000695	0.0105	CbGpPWpGaD
Gemcitabine—POLD1—DNA strand elongation—PCNA—psoriasis	0.000665	0.0101	CbGpPWpGaD
Gemcitabine—RRM2—E2F mediated regulation of DNA replication—PCNA—psoriasis	0.000653	0.00987	CbGpPWpGaD
Gemcitabine—POLA1—Lagging Strand Synthesis—PCNA—psoriasis	0.000641	0.00969	CbGpPWpGaD
Gemcitabine—POLD1—Global Genomic NER (GG-NER)—PCNA—psoriasis	0.000634	0.00958	CbGpPWpGaD
Gemcitabine—POLE—Global Genomic NER (GG-NER)—PCNA—psoriasis	0.000612	0.00925	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IL22—psoriasis	0.000611	0.00924	CbGpPWpGaD
Gemcitabine—CDA—Nucleotide metabolism—CAT—psoriasis	0.00061	0.00922	CbGpPWpGaD
Gemcitabine—CMPK1—skin of body—psoriasis	0.000599	0.101	CbGeAlD
Gemcitabine—POLA1—Telomere C-strand (Lagging Strand) Synthesis—PCNA—psoriasis	0.000596	0.00901	CbGpPWpGaD
Gemcitabine—POLD1—DNA Replication—PCNA—psoriasis	0.000535	0.00809	CbGpPWpGaD
Gemcitabine—POLE—DNA Replication—PCNA—psoriasis	0.000517	0.00781	CbGpPWpGaD
Gemcitabine—CDA—tendon—psoriasis	0.000513	0.0866	CbGeAlD
Gemcitabine—POLD1—Transcription-coupled NER (TC-NER)—PCNA—psoriasis	0.000506	0.00766	CbGpPWpGaD
Gemcitabine—POLA1—Extension of Telomeres—PCNA—psoriasis	0.000495	0.00749	CbGpPWpGaD
Gemcitabine—POLE—Transcription-coupled NER (TC-NER)—PCNA—psoriasis	0.000489	0.00739	CbGpPWpGaD
Gemcitabine—SLC28A1—SLC-mediated transmembrane transport—CP—psoriasis	0.000487	0.00736	CbGpPWpGaD
Gemcitabine—SLC29A2—tendon—psoriasis	0.00048	0.0809	CbGeAlD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	0.000477	0.00722	CbGpPWpGaD
Gemcitabine—POLD1—Nucleotide Excision Repair—PCNA—psoriasis	0.000465	0.00704	CbGpPWpGaD
Gemcitabine—RRM2—skin of body—psoriasis	0.000462	0.0781	CbGeAlD
Gemcitabine—RRM1—Nucleotide metabolism—CAT—psoriasis	0.000462	0.00699	CbGpPWpGaD
Gemcitabine—POLA1—DNA strand elongation—PCNA—psoriasis	0.000458	0.00692	CbGpPWpGaD
Gemcitabine—POLE—Nucleotide Excision Repair—PCNA—psoriasis	0.00045	0.0068	CbGpPWpGaD
Gemcitabine—POLA1—E2F mediated regulation of DNA replication—PCNA—psoriasis	0.000447	0.00675	CbGpPWpGaD
Gemcitabine—TYMS—E2F mediated regulation of DNA replication—PCNA—psoriasis	0.000428	0.00647	CbGpPWpGaD
Gemcitabine—POLE—tendon—psoriasis	0.000427	0.0721	CbGeAlD
Gemcitabine—SLC29A2—SLC-mediated transmembrane transport—CP—psoriasis	0.000397	0.006	CbGpPWpGaD
Gemcitabine—TYMS—Vitamin A—Acitretin—psoriasis	0.00039	0.0797	CbGdCrCtD
Gemcitabine—CDA—Fluoropyrimidine Activity—TP53—psoriasis	0.000385	0.00582	CbGpPWpGaD
Gemcitabine—RRM1—skin of body—psoriasis	0.000384	0.0648	CbGeAlD
Gemcitabine—RRM2—Nucleotide metabolism—CAT—psoriasis	0.000381	0.00576	CbGpPWpGaD
Gemcitabine—SLC28A3—SLC-mediated transmembrane transport—CP—psoriasis	0.000369	0.00558	CbGpPWpGaD
Gemcitabine—POLA1—tendon—psoriasis	0.000368	0.0622	CbGeAlD
Gemcitabine—POLA1—DNA Replication—PCNA—psoriasis	0.000368	0.00557	CbGpPWpGaD
Gemcitabine—RRM1—Retinoblastoma (RB) in Cancer—PCNA—psoriasis	0.000365	0.00552	CbGpPWpGaD
Gemcitabine—DCK—Nucleotide metabolism—CAT—psoriasis	0.000356	0.00538	CbGpPWpGaD
Gemcitabine—RRM2—tendon—psoriasis	0.000352	0.0594	CbGeAlD
Gemcitabine—POLE—G1 to S cell cycle control—PCNA—psoriasis	0.000351	0.00531	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—NDUFA5—psoriasis	0.000351	0.00531	CbGpPWpGaD
Gemcitabine—TYMS—skin of body—psoriasis	0.000348	0.0588	CbGeAlD
Gemcitabine—POLD1—Telomere Maintenance—PCNA—psoriasis	0.000326	0.00493	CbGpPWpGaD
Gemcitabine—POLE—Telomere Maintenance—PCNA—psoriasis	0.000315	0.00476	CbGpPWpGaD
Gemcitabine—RRM2—Retinoblastoma (RB) in Cancer—PCNA—psoriasis	0.000301	0.00455	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—CYP2S1—psoriasis	0.000299	0.00452	CbGpPWpGaD
Gemcitabine—RRM1—tendon—psoriasis	0.000292	0.0494	CbGeAlD
Gemcitabine—RRM1—Fluoropyrimidine Activity—TP53—psoriasis	0.000292	0.00441	CbGpPWpGaD
Gemcitabine—POLE—Retinoblastoma (RB) in Cancer—PCNA—psoriasis	0.000289	0.00436	CbGpPWpGaD
Gemcitabine—DCK—Retinoblastoma (RB) in Cancer—PCNA—psoriasis	0.000281	0.00425	CbGpPWpGaD
Gemcitabine—POLD1—Synthesis of DNA—PCNA—psoriasis	0.000276	0.00418	CbGpPWpGaD
Gemcitabine—SLC29A1—SLC-mediated transmembrane transport—CP—psoriasis	0.000275	0.00416	CbGpPWpGaD
Gemcitabine—TYMS—Alitretinoin—Acitretin—psoriasis	0.000273	0.0557	CbGdCrCtD
Gemcitabine—TYMS—Isotretinoin—Acitretin—psoriasis	0.000273	0.0557	CbGdCrCtD
Gemcitabine—TYMS—Tretinoin—Acitretin—psoriasis	0.000273	0.0557	CbGdCrCtD
Gemcitabine—POLD1—Chromosome Maintenance—PCNA—psoriasis	0.000272	0.00411	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	0.000269	0.00407	CbGpPWpGaD
Gemcitabine—POLE—Synthesis of DNA—PCNA—psoriasis	0.000267	0.00403	CbGpPWpGaD
Gemcitabine—SLC29A1—Fluoropyrimidine Activity—TP53—psoriasis	0.000267	0.00403	CbGpPWpGaD
Gemcitabine—TYMS—tendon—psoriasis	0.000265	0.0448	CbGeAlD
Gemcitabine—POLE—Chromosome Maintenance—PCNA—psoriasis	0.000262	0.00397	CbGpPWpGaD
Gemcitabine—POLD1—DNA Replication—PCNA—psoriasis	0.000259	0.00392	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	0.000258	0.0039	CbGpPWpGaD
Gemcitabine—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000253	0.00382	CbGpPWpGaD
Gemcitabine—RRM2—G1/S Transition—PCNA—psoriasis	0.000251	0.0038	CbGpPWpGaD
Gemcitabine—POLE—DNA Replication—PCNA—psoriasis	0.00025	0.00378	CbGpPWpGaD
Gemcitabine—TYMS—Nucleotide metabolism—CAT—psoriasis	0.000249	0.00377	CbGpPWpGaD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—CP—psoriasis	0.000247	0.00374	CbGpPWpGaD
Gemcitabine—POLE—Mitotic M-M/G1 phases—PTTG1—psoriasis	0.000244	0.00369	CbGpPWpGaD
Gemcitabine—POLD1—DNA Repair—PCNA—psoriasis	0.000242	0.00367	CbGpPWpGaD
Gemcitabine—POLE—G1/S Transition—PCNA—psoriasis	0.000241	0.00364	CbGpPWpGaD
Gemcitabine—RRM2—Fluoropyrimidine Activity—TP53—psoriasis	0.00024	0.00363	CbGpPWpGaD
Gemcitabine—SLC29A1—tendon—psoriasis	0.000238	0.0401	CbGeAlD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—CARM1—psoriasis	0.000236	0.00357	CbGpPWpGaD
Gemcitabine—POLE—DNA Repair—PCNA—psoriasis	0.000234	0.00354	CbGpPWpGaD
Gemcitabine—DCK—tendon—psoriasis	0.000227	0.0383	CbGeAlD
Gemcitabine—POLD1—S Phase—PCNA—psoriasis	0.000227	0.00343	CbGpPWpGaD
Gemcitabine—POLA1—Telomere Maintenance—PCNA—psoriasis	0.000224	0.00339	CbGpPWpGaD
Gemcitabine—POLE—S Phase—PCNA—psoriasis	0.000219	0.00331	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—NDUFA5—psoriasis	0.000217	0.00328	CbGpPWpGaD
Gemcitabine—ABCC10—tendon—psoriasis	0.000216	0.0365	CbGeAlD
Gemcitabine—RRM2—Mitotic G1-G1/S phases—PCNA—psoriasis	0.000212	0.0032	CbGpPWpGaD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—PCNA—psoriasis	0.000206	0.00311	CbGpPWpGaD
Gemcitabine—POLE—Mitotic G1-G1/S phases—PCNA—psoriasis	0.000203	0.00307	CbGpPWpGaD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—CP—psoriasis	0.000202	0.00305	CbGpPWpGaD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—PCNA—psoriasis	0.000197	0.00298	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	0.000195	0.00294	CbGpPWpGaD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—CARM1—psoriasis	0.000192	0.00291	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—PTTG1—psoriasis	0.00019	0.00288	CbGpPWpGaD
Gemcitabine—POLA1—Synthesis of DNA—PCNA—psoriasis	0.00019	0.00287	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—PTTG1—psoriasis	0.000189	0.00286	CbGpPWpGaD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—CP—psoriasis	0.000187	0.00283	CbGpPWpGaD
Gemcitabine—POLA1—Chromosome Maintenance—PCNA—psoriasis	0.000187	0.00283	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—CYP2S1—psoriasis	0.000184	0.00279	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—PTTG1—psoriasis	0.000183	0.00276	CbGpPWpGaD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—CARM1—psoriasis	0.000179	0.0027	CbGpPWpGaD
Gemcitabine—POLA1—DNA Replication—PCNA—psoriasis	0.000178	0.0027	CbGpPWpGaD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—CP—psoriasis	0.000176	0.00267	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic M-M/G1 phases—PTTG1—psoriasis	0.000174	0.00263	CbGpPWpGaD
Gemcitabine—POLA1—G1/S Transition—PCNA—psoriasis	0.000172	0.0026	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—PTTG1—psoriasis	0.00017	0.00257	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—PTTG1—psoriasis	0.000169	0.00256	CbGpPWpGaD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—CARM1—psoriasis	0.000168	0.00254	CbGpPWpGaD
Gemcitabine—TYMS—G1/S Transition—PCNA—psoriasis	0.000164	0.00249	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—NDUFA5—psoriasis	0.000164	0.00249	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	0.000164	0.00247	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—PTTG1—psoriasis	0.000163	0.00247	CbGpPWpGaD
Gemcitabine—TYMS—Fluoropyrimidine Activity—TP53—psoriasis	0.000157	0.00238	CbGpPWpGaD
Gemcitabine—POLA1—S Phase—PCNA—psoriasis	0.000156	0.00236	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	0.00015	0.00227	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—CARM1—psoriasis	0.000146	0.00221	CbGpPWpGaD
Gemcitabine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000145	0.0022	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—PCNA—psoriasis	0.000145	0.00219	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—CYP2S1—psoriasis	0.00014	0.00211	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—CP—psoriasis	0.00014	0.00211	CbGpPWpGaD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—PCNA—psoriasis	0.000139	0.0021	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—NDUFA5—psoriasis	0.000135	0.00205	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—NDUFA5—psoriasis	0.000135	0.00204	CbGpPWpGaD
Gemcitabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—psoriasis	0.000134	0.00203	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—CARM1—psoriasis	0.000133	0.00202	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—PTTG1—psoriasis	0.00013	0.00197	CbGpPWpGaD
Gemcitabine—POLE—G1 to S cell cycle control—TP53—psoriasis	0.000129	0.00195	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—NDUFA5—psoriasis	0.000127	0.00191	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—PTTG1—psoriasis	0.000125	0.00189	CbGpPWpGaD
Gemcitabine—POLD1—Danazol—Hydrocortisone—psoriasis	0.000116	0.0238	CbGdCrCtD
Gemcitabine—POLA1—Cell Cycle—PTTG1—psoriasis	0.000116	0.00176	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—HLA-C—psoriasis	0.000116	0.00175	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CYP2S1—psoriasis	0.000115	0.00174	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IL13—psoriasis	0.000115	0.00174	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CYP2S1—psoriasis	0.000114	0.00173	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—PTTG1—psoriasis	0.000112	0.00169	CbGpPWpGaD
Gemcitabine—RRM2—Retinoblastoma (RB) in Cancer—TP53—psoriasis	0.000111	0.00167	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	0.00011	0.00166	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	0.000108	0.00164	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CYP2S1—psoriasis	0.000108	0.00163	CbGpPWpGaD
Gemcitabine—POLE—Retinoblastoma (RB) in Cancer—TP53—psoriasis	0.000106	0.0016	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IL17A—psoriasis	0.000106	0.0016	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	0.000105	0.00159	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	0.000104	0.00158	CbGpPWpGaD
Gemcitabine—DCK—Retinoblastoma (RB) in Cancer—TP53—psoriasis	0.000103	0.00156	CbGpPWpGaD
Gemcitabine—DCK—Desoximetasone—Clobetasol propionate—psoriasis	0.000103	0.021	CbGdCrCtD
Gemcitabine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000101	0.00153	CbGpPWpGaD
Gemcitabine—POLD1—Danazol—Prednisone—psoriasis	0.0001	0.0205	CbGdCrCtD
Gemcitabine—DCK—Diflorasone—Clobetasol propionate—psoriasis	9.96e-05	0.0203	CbGdCrCtD
Gemcitabine—ABCB1—Allograft Rejection—IL12B—psoriasis	9.84e-05	0.00149	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—HLA-E—psoriasis	9.61e-05	0.00145	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	9.47e-05	0.00143	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	9.21e-05	0.00139	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—LEP—psoriasis	9.09e-05	0.00137	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—CARM1—psoriasis	9.01e-05	0.00136	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—CAT—psoriasis	8.97e-05	0.00136	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—NDUFA5—psoriasis	8.87e-05	0.00134	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	8.82e-05	0.00133	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—NOS2—psoriasis	8.47e-05	0.00128	CbGpPWpGaD
Gemcitabine—DCK—Desoximetasone—Fluocinonide—psoriasis	8.22e-05	0.0168	CbGdCrCtD
Gemcitabine—DCK—Desoximetasone—Beclomethasone—psoriasis	8.22e-05	0.0168	CbGdCrCtD
Gemcitabine—TYMS—Triamcinolone—Clobetasol propionate—psoriasis	8.14e-05	0.0166	CbGdCrCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	8.12e-05	0.00123	CbGpPWpGaD
Gemcitabine—DCK—Desoximetasone—Fluocinolone Acetonide—psoriasis	7.99e-05	0.0163	CbGdCrCtD
Gemcitabine—DCK—Diflorasone—Fluocinonide—psoriasis	7.98e-05	0.0163	CbGdCrCtD
Gemcitabine—DCK—Diflorasone—Beclomethasone—psoriasis	7.98e-05	0.0163	CbGdCrCtD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	7.95e-05	0.0012	CbGpPWpGaD
Gemcitabine—TYMS—Fluticasone Propionate—Clobetasol propionate—psoriasis	7.94e-05	0.0162	CbGdCrCtD
Gemcitabine—TYMS—Circadian rythm related genes—PPARG—psoriasis	7.92e-05	0.0012	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—PCNA—psoriasis	7.76e-05	0.00117	CbGpPWpGaD
Gemcitabine—DCK—Diflorasone—Fluocinolone Acetonide—psoriasis	7.76e-05	0.0158	CbGdCrCtD
Gemcitabine—POLD1—Cell Cycle, Mitotic—PCNA—psoriasis	7.71e-05	0.00117	CbGpPWpGaD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—psoriasis	7.56e-05	0.00114	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CYP2S1—psoriasis	7.55e-05	0.00114	CbGpPWpGaD
Gemcitabine—Hypertension—Triamcinolone—psoriasis	7.52e-05	0.000394	CcSEcCtD
Gemcitabine—TYMS—Diflorasone—Clobetasol propionate—psoriasis	7.5e-05	0.0153	CbGdCrCtD
Gemcitabine—Infection—Hydrocortisone—psoriasis	7.5e-05	0.000393	CcSEcCtD
Gemcitabine—Insomnia—Mycophenolate mofetil—psoriasis	7.49e-05	0.000392	CcSEcCtD
Gemcitabine—Hyperhidrosis—Prednisolone—psoriasis	7.47e-05	0.000391	CcSEcCtD
Gemcitabine—POLE—Cell Cycle, Mitotic—PCNA—psoriasis	7.45e-05	0.00113	CbGpPWpGaD
Gemcitabine—Nausea—Hydroxyurea—psoriasis	7.44e-05	0.00039	CcSEcCtD
Gemcitabine—Paraesthesia—Mycophenolate mofetil—psoriasis	7.44e-05	0.00039	CcSEcCtD
Gemcitabine—Pruritus—Mycophenolic acid—psoriasis	7.43e-05	0.000389	CcSEcCtD
Gemcitabine—Myalgia—Triamcinolone—psoriasis	7.41e-05	0.000388	CcSEcCtD
Gemcitabine—Nervous system disorder—Hydrocortisone—psoriasis	7.4e-05	0.000388	CcSEcCtD
Gemcitabine—Pneumonia—Methotrexate—psoriasis	7.4e-05	0.000388	CcSEcCtD
Gemcitabine—Dyspnoea—Mycophenolate mofetil—psoriasis	7.39e-05	0.000387	CcSEcCtD
Gemcitabine—Decreased appetite—Cyclosporine—psoriasis	7.38e-05	0.000387	CcSEcCtD
Gemcitabine—Somnolence—Mycophenolate mofetil—psoriasis	7.36e-05	0.000386	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Cyclosporine—psoriasis	7.33e-05	0.000384	CcSEcCtD
Gemcitabine—Skin disorder—Hydrocortisone—psoriasis	7.33e-05	0.000384	CcSEcCtD
Gemcitabine—Ill-defined disorder—Dexamethasone—psoriasis	7.33e-05	0.000384	CcSEcCtD
Gemcitabine—Ill-defined disorder—Betamethasone—psoriasis	7.33e-05	0.000384	CcSEcCtD
Gemcitabine—Discomfort—Triamcinolone—psoriasis	7.32e-05	0.000384	CcSEcCtD
Gemcitabine—Fatigue—Cyclosporine—psoriasis	7.32e-05	0.000384	CcSEcCtD
Gemcitabine—Hyperhidrosis—Hydrocortisone—psoriasis	7.3e-05	0.000382	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Methotrexate—psoriasis	7.29e-05	0.000382	CcSEcCtD
Gemcitabine—Pain—Cyclosporine—psoriasis	7.26e-05	0.00038	CcSEcCtD
Gemcitabine—Constipation—Cyclosporine—psoriasis	7.26e-05	0.00038	CcSEcCtD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—TP53—psoriasis	7.24e-05	0.0011	CbGpPWpGaD
Gemcitabine—Renal failure—Methotrexate—psoriasis	7.23e-05	0.000379	CcSEcCtD
Gemcitabine—Decreased appetite—Mycophenolate mofetil—psoriasis	7.2e-05	0.000377	CcSEcCtD
Gemcitabine—ABCB1—Allograft Rejection—IL10—psoriasis	7.2e-05	0.00109	CbGpPWpGaD
Gemcitabine—Anorexia—Hydrocortisone—psoriasis	7.19e-05	0.000377	CcSEcCtD
Gemcitabine—POLA1—Norethindrone—Hydrocortisone—psoriasis	7.19e-05	0.0147	CbGdCrCtD
Gemcitabine—Diarrhoea—Mycophenolic acid—psoriasis	7.18e-05	0.000376	CcSEcCtD
Gemcitabine—Stomatitis—Methotrexate—psoriasis	7.17e-05	0.000376	CcSEcCtD
Gemcitabine—Angiopathy—Prednisone—psoriasis	7.17e-05	0.000376	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	7.16e-05	0.00108	CbGpPWpGaD
Gemcitabine—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	7.15e-05	0.000375	CcSEcCtD
Gemcitabine—Immune system disorder—Prednisone—psoriasis	7.14e-05	0.000374	CcSEcCtD
Gemcitabine—Malaise—Betamethasone—psoriasis	7.12e-05	0.000373	CcSEcCtD
Gemcitabine—Malaise—Dexamethasone—psoriasis	7.12e-05	0.000373	CcSEcCtD
Gemcitabine—Oedema—Triamcinolone—psoriasis	7.11e-05	0.000372	CcSEcCtD
Gemcitabine—Anaphylactic shock—Triamcinolone—psoriasis	7.11e-05	0.000372	CcSEcCtD
Gemcitabine—Pain—Mycophenolate mofetil—psoriasis	7.08e-05	0.000371	CcSEcCtD
Gemcitabine—Constipation—Mycophenolate mofetil—psoriasis	7.08e-05	0.000371	CcSEcCtD
Gemcitabine—Arrhythmia—Prednisone—psoriasis	7.06e-05	0.00037	CcSEcCtD
Gemcitabine—Infection—Triamcinolone—psoriasis	7.06e-05	0.00037	CcSEcCtD
Gemcitabine—Sweating—Methotrexate—psoriasis	7.05e-05	0.00037	CcSEcCtD
Gemcitabine—Hypotension—Hydrocortisone—psoriasis	7.05e-05	0.000369	CcSEcCtD
Gemcitabine—Haematuria—Methotrexate—psoriasis	7.02e-05	0.000367	CcSEcCtD
Gemcitabine—ABCB1—Allograft Rejection—IL4—psoriasis	7e-05	0.00106	CbGpPWpGaD
Gemcitabine—Feeling abnormal—Cyclosporine—psoriasis	7e-05	0.000367	CcSEcCtD
Gemcitabine—Insomnia—Prednisolone—psoriasis	6.99e-05	0.000366	CcSEcCtD
Gemcitabine—Alopecia—Prednisone—psoriasis	6.98e-05	0.000366	CcSEcCtD
Gemcitabine—CMPK1—Metabolism—APOE—psoriasis	6.97e-05	0.00105	CbGpPWpGaD
Gemcitabine—Hepatobiliary disease—Methotrexate—psoriasis	6.96e-05	0.000365	CcSEcCtD
Gemcitabine—Paraesthesia—Prednisolone—psoriasis	6.94e-05	0.000363	CcSEcCtD
Gemcitabine—RRM2—Cell Cycle—PCNA—psoriasis	6.94e-05	0.00105	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—PCNA—psoriasis	6.9e-05	0.00104	CbGpPWpGaD
Gemcitabine—Erythema—Prednisone—psoriasis	6.88e-05	0.00036	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Hydrocortisone—psoriasis	6.88e-05	0.00036	CcSEcCtD
Gemcitabine—Hyperhidrosis—Triamcinolone—psoriasis	6.87e-05	0.00036	CcSEcCtD
Gemcitabine—Agranulocytosis—Methotrexate—psoriasis	6.87e-05	0.00036	CcSEcCtD
Gemcitabine—ABCB1—Allograft Rejection—HLA-B—psoriasis	6.84e-05	0.00103	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	6.84e-05	0.00103	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—CARM1—psoriasis	6.83e-05	0.00103	CbGpPWpGaD
Gemcitabine—Feeling abnormal—Mycophenolate mofetil—psoriasis	6.83e-05	0.000358	CcSEcCtD
Gemcitabine—Insomnia—Hydrocortisone—psoriasis	6.83e-05	0.000358	CcSEcCtD
Gemcitabine—Hypertension—Dexamethasone—psoriasis	6.82e-05	0.000357	CcSEcCtD
Gemcitabine—Hypertension—Betamethasone—psoriasis	6.82e-05	0.000357	CcSEcCtD
Gemcitabine—Paraesthesia—Hydrocortisone—psoriasis	6.78e-05	0.000355	CcSEcCtD
Gemcitabine—Myalgia—Betamethasone—psoriasis	6.73e-05	0.000352	CcSEcCtD
Gemcitabine—Myalgia—Dexamethasone—psoriasis	6.73e-05	0.000352	CcSEcCtD
Gemcitabine—Body temperature increased—Cyclosporine—psoriasis	6.71e-05	0.000352	CcSEcCtD
Gemcitabine—Vomiting—Mycophenolic acid—psoriasis	6.67e-05	0.00035	CcSEcCtD
Gemcitabine—TYMS—Clobetasol propionate—Beclomethasone—psoriasis	6.67e-05	0.0136	CbGdCrCtD
Gemcitabine—TYMS—Clobetasol propionate—Fluocinonide—psoriasis	6.67e-05	0.0136	CbGdCrCtD
Gemcitabine—POLE—Cell Cycle—PCNA—psoriasis	6.66e-05	0.00101	CbGpPWpGaD
Gemcitabine—Discomfort—Dexamethasone—psoriasis	6.65e-05	0.000348	CcSEcCtD
Gemcitabine—Discomfort—Betamethasone—psoriasis	6.65e-05	0.000348	CcSEcCtD
Gemcitabine—Haemoglobin—Methotrexate—psoriasis	6.64e-05	0.000348	CcSEcCtD
Gemcitabine—Rash—Mycophenolic acid—psoriasis	6.62e-05	0.000347	CcSEcCtD
Gemcitabine—Dermatitis—Mycophenolic acid—psoriasis	6.61e-05	0.000346	CcSEcCtD
Gemcitabine—Pain—Prednisolone—psoriasis	6.61e-05	0.000346	CcSEcCtD
Gemcitabine—Haemorrhage—Methotrexate—psoriasis	6.61e-05	0.000346	CcSEcCtD
Gemcitabine—TYMS—Flunisolide—Fluocinonide—psoriasis	6.59e-05	0.0135	CbGdCrCtD
Gemcitabine—TYMS—Budesonide—Clobetasol propionate—psoriasis	6.58e-05	0.0134	CbGdCrCtD
Gemcitabine—Headache—Mycophenolic acid—psoriasis	6.58e-05	0.000344	CcSEcCtD
Gemcitabine—Decreased appetite—Hydrocortisone—psoriasis	6.56e-05	0.000344	CcSEcCtD
Gemcitabine—Pharyngitis—Methotrexate—psoriasis	6.56e-05	0.000343	CcSEcCtD
Gemcitabine—Body temperature increased—Mycophenolate mofetil—psoriasis	6.55e-05	0.000343	CcSEcCtD
Gemcitabine—Urinary tract disorder—Methotrexate—psoriasis	6.52e-05	0.000342	CcSEcCtD
Gemcitabine—TYMS—Triamcinolone—Beclomethasone—psoriasis	6.52e-05	0.0133	CbGdCrCtD
Gemcitabine—TYMS—Triamcinolone—Fluocinonide—psoriasis	6.52e-05	0.0133	CbGdCrCtD
Gemcitabine—Gastrointestinal disorder—Hydrocortisone—psoriasis	6.52e-05	0.000341	CcSEcCtD
Gemcitabine—Fatigue—Hydrocortisone—psoriasis	6.51e-05	0.000341	CcSEcCtD
Gemcitabine—TYMS—Clobetasol propionate—Fluocinolone Acetonide—psoriasis	6.48e-05	0.0132	CbGdCrCtD
Gemcitabine—Urethral disorder—Methotrexate—psoriasis	6.47e-05	0.000339	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Triamcinolone—psoriasis	6.47e-05	0.000339	CcSEcCtD
Gemcitabine—Pain—Hydrocortisone—psoriasis	6.45e-05	0.000338	CcSEcCtD
Gemcitabine—Anaphylactic shock—Dexamethasone—psoriasis	6.45e-05	0.000338	CcSEcCtD
Gemcitabine—Anaphylactic shock—Betamethasone—psoriasis	6.45e-05	0.000338	CcSEcCtD
Gemcitabine—Oedema—Dexamethasone—psoriasis	6.45e-05	0.000338	CcSEcCtD
Gemcitabine—Oedema—Betamethasone—psoriasis	6.45e-05	0.000338	CcSEcCtD
Gemcitabine—Insomnia—Triamcinolone—psoriasis	6.43e-05	0.000337	CcSEcCtD
Gemcitabine—Infection—Betamethasone—psoriasis	6.41e-05	0.000336	CcSEcCtD
Gemcitabine—Infection—Dexamethasone—psoriasis	6.41e-05	0.000336	CcSEcCtD
Gemcitabine—TYMS—Flunisolide—Fluocinolone Acetonide—psoriasis	6.4e-05	0.0131	CbGdCrCtD
Gemcitabine—Ill-defined disorder—Prednisone—psoriasis	6.38e-05	0.000334	CcSEcCtD
Gemcitabine—Paraesthesia—Triamcinolone—psoriasis	6.38e-05	0.000334	CcSEcCtD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	6.37e-05	0.000963	CbGpPWpGaD
Gemcitabine—Feeling abnormal—Prednisolone—psoriasis	6.37e-05	0.000334	CcSEcCtD
Gemcitabine—Anaemia—Prednisone—psoriasis	6.36e-05	0.000333	CcSEcCtD
Gemcitabine—TYMS—Fluticasone Propionate—Fluocinonide—psoriasis	6.36e-05	0.013	CbGdCrCtD
Gemcitabine—TYMS—Fluticasone Propionate—Beclomethasone—psoriasis	6.36e-05	0.013	CbGdCrCtD
Gemcitabine—ABCB1—Allograft Rejection—HLA-A—psoriasis	6.34e-05	0.000959	CbGpPWpGaD
Gemcitabine—Dyspnoea—Triamcinolone—psoriasis	6.34e-05	0.000332	CcSEcCtD
Gemcitabine—TYMS—Triamcinolone—Fluocinolone Acetonide—psoriasis	6.33e-05	0.0129	CbGdCrCtD
Gemcitabine—Nervous system disorder—Betamethasone—psoriasis	6.32e-05	0.000331	CcSEcCtD
Gemcitabine—Nervous system disorder—Dexamethasone—psoriasis	6.32e-05	0.000331	CcSEcCtD
Gemcitabine—Thrombocytopenia—Betamethasone—psoriasis	6.31e-05	0.000331	CcSEcCtD
Gemcitabine—Thrombocytopenia—Dexamethasone—psoriasis	6.31e-05	0.000331	CcSEcCtD
Gemcitabine—Erythema multiforme—Methotrexate—psoriasis	6.25e-05	0.000327	CcSEcCtD
Gemcitabine—Nausea—Mycophenolic acid—psoriasis	6.23e-05	0.000327	CcSEcCtD
Gemcitabine—Hyperhidrosis—Betamethasone—psoriasis	6.23e-05	0.000327	CcSEcCtD
Gemcitabine—Hyperhidrosis—Dexamethasone—psoriasis	6.23e-05	0.000327	CcSEcCtD
Gemcitabine—Feeling abnormal—Hydrocortisone—psoriasis	6.22e-05	0.000326	CcSEcCtD
Gemcitabine—Malaise—Prednisone—psoriasis	6.2e-05	0.000325	CcSEcCtD
Gemcitabine—TYMS—Fluticasone Propionate—Fluocinolone Acetonide—psoriasis	6.18e-05	0.0126	CbGdCrCtD
Gemcitabine—Anorexia—Dexamethasone—psoriasis	6.15e-05	0.000322	CcSEcCtD
Gemcitabine—Anorexia—Betamethasone—psoriasis	6.15e-05	0.000322	CcSEcCtD
Gemcitabine—Cardiac disorder—Methotrexate—psoriasis	6.13e-05	0.000321	CcSEcCtD
Gemcitabine—Fatigue—Triamcinolone—psoriasis	6.13e-05	0.000321	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	6.11e-05	0.000923	CbGpPWpGaD
Gemcitabine—Asthenia—Cyclosporine—psoriasis	6.09e-05	0.000319	CcSEcCtD
Gemcitabine—Pain—Triamcinolone—psoriasis	6.08e-05	0.000318	CcSEcCtD
Gemcitabine—CMPK1—Metabolism—PPARG—psoriasis	6.07e-05	0.000918	CbGpPWpGaD
Gemcitabine—Hypotension—Betamethasone—psoriasis	6.02e-05	0.000316	CcSEcCtD
Gemcitabine—Hypotension—Dexamethasone—psoriasis	6.02e-05	0.000316	CcSEcCtD
Gemcitabine—TYMS—Diflorasone—Beclomethasone—psoriasis	6.01e-05	0.0123	CbGdCrCtD
Gemcitabine—TYMS—Diflorasone—Fluocinonide—psoriasis	6.01e-05	0.0123	CbGdCrCtD
Gemcitabine—Pruritus—Cyclosporine—psoriasis	6.01e-05	0.000315	CcSEcCtD
Gemcitabine—Angiopathy—Methotrexate—psoriasis	5.99e-05	0.000314	CcSEcCtD
Gemcitabine—Immune system disorder—Methotrexate—psoriasis	5.97e-05	0.000313	CcSEcCtD
Gemcitabine—Body temperature increased—Hydrocortisone—psoriasis	5.97e-05	0.000313	CcSEcCtD
Gemcitabine—Mediastinal disorder—Methotrexate—psoriasis	5.95e-05	0.000312	CcSEcCtD
Gemcitabine—Asthenia—Mycophenolate mofetil—psoriasis	5.94e-05	0.000311	CcSEcCtD
Gemcitabine—Hypertension—Prednisone—psoriasis	5.94e-05	0.000311	CcSEcCtD
Gemcitabine—Chills—Methotrexate—psoriasis	5.93e-05	0.00031	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	5.88e-05	0.000889	CbGpPWpGaD
Gemcitabine—Musculoskeletal discomfort—Dexamethasone—psoriasis	5.87e-05	0.000308	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Betamethasone—psoriasis	5.87e-05	0.000308	CcSEcCtD
Gemcitabine—Pruritus—Mycophenolate mofetil—psoriasis	5.86e-05	0.000307	CcSEcCtD
Gemcitabine—Arthralgia—Prednisone—psoriasis	5.86e-05	0.000307	CcSEcCtD
Gemcitabine—Myalgia—Prednisone—psoriasis	5.86e-05	0.000307	CcSEcCtD
Gemcitabine—Feeling abnormal—Triamcinolone—psoriasis	5.86e-05	0.000307	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	5.85e-05	0.000885	CbGpPWpGaD
Gemcitabine—TYMS—Diflorasone—Fluocinolone Acetonide—psoriasis	5.84e-05	0.0119	CbGdCrCtD
Gemcitabine—Alopecia—Methotrexate—psoriasis	5.84e-05	0.000306	CcSEcCtD
Gemcitabine—Insomnia—Betamethasone—psoriasis	5.83e-05	0.000305	CcSEcCtD
Gemcitabine—Insomnia—Dexamethasone—psoriasis	5.83e-05	0.000305	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	5.82e-05	0.000305	CcSEcCtD
Gemcitabine—Diarrhoea—Cyclosporine—psoriasis	5.81e-05	0.000304	CcSEcCtD
Gemcitabine—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	5.79e-05	0.000876	CbGpPWpGaD
Gemcitabine—Paraesthesia—Betamethasone—psoriasis	5.79e-05	0.000303	CcSEcCtD
Gemcitabine—Paraesthesia—Dexamethasone—psoriasis	5.79e-05	0.000303	CcSEcCtD
Gemcitabine—Discomfort—Prednisone—psoriasis	5.79e-05	0.000303	CcSEcCtD
Gemcitabine—Erythema—Methotrexate—psoriasis	5.75e-05	0.000301	CcSEcCtD
Gemcitabine—POLA1—Levonorgestrel—Hydrocortisone—psoriasis	5.72e-05	0.0117	CbGdCrCtD
Gemcitabine—Diarrhoea—Mycophenolate mofetil—psoriasis	5.67e-05	0.000297	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	5.63e-05	0.000851	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CARM1—psoriasis	5.62e-05	0.00085	CbGpPWpGaD
Gemcitabine—Body temperature increased—Triamcinolone—psoriasis	5.62e-05	0.000294	CcSEcCtD
Gemcitabine—TYMS—Circadian rythm related genes—JUN—psoriasis	5.62e-05	0.000849	CbGpPWpGaD
Gemcitabine—Anaphylactic shock—Prednisone—psoriasis	5.62e-05	0.000294	CcSEcCtD
Gemcitabine—Oedema—Prednisone—psoriasis	5.62e-05	0.000294	CcSEcCtD
Gemcitabine—Decreased appetite—Dexamethasone—psoriasis	5.6e-05	0.000294	CcSEcCtD
Gemcitabine—Decreased appetite—Betamethasone—psoriasis	5.6e-05	0.000294	CcSEcCtD
Gemcitabine—POLD1—Metabolism—CARM1—psoriasis	5.59e-05	0.000845	CbGpPWpGaD
Gemcitabine—Infection—Prednisone—psoriasis	5.58e-05	0.000292	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Dexamethasone—psoriasis	5.57e-05	0.000292	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Betamethasone—psoriasis	5.57e-05	0.000292	CcSEcCtD
Gemcitabine—Back pain—Methotrexate—psoriasis	5.56e-05	0.000291	CcSEcCtD
Gemcitabine—Fatigue—Betamethasone—psoriasis	5.56e-05	0.000291	CcSEcCtD
Gemcitabine—Fatigue—Dexamethasone—psoriasis	5.56e-05	0.000291	CcSEcCtD
Gemcitabine—CDA—Metabolism—CAT—psoriasis	5.54e-05	0.000838	CbGpPWpGaD
Gemcitabine—Pain—Betamethasone—psoriasis	5.51e-05	0.000289	CcSEcCtD
Gemcitabine—Pain—Dexamethasone—psoriasis	5.51e-05	0.000289	CcSEcCtD
Gemcitabine—Nervous system disorder—Prednisone—psoriasis	5.51e-05	0.000288	CcSEcCtD
Gemcitabine—Skin disorder—Prednisone—psoriasis	5.45e-05	0.000286	CcSEcCtD
Gemcitabine—Hyperhidrosis—Prednisone—psoriasis	5.43e-05	0.000284	CcSEcCtD
Gemcitabine—Asthenia—Hydrocortisone—psoriasis	5.41e-05	0.000284	CcSEcCtD
Gemcitabine—Vomiting—Cyclosporine—psoriasis	5.4e-05	0.000283	CcSEcCtD
Gemcitabine—Rash—Cyclosporine—psoriasis	5.35e-05	0.00028	CcSEcCtD
Gemcitabine—Anorexia—Prednisone—psoriasis	5.35e-05	0.00028	CcSEcCtD
Gemcitabine—Dermatitis—Cyclosporine—psoriasis	5.35e-05	0.00028	CcSEcCtD
Gemcitabine—Pruritus—Hydrocortisone—psoriasis	5.34e-05	0.00028	CcSEcCtD
Gemcitabine—Ill-defined disorder—Methotrexate—psoriasis	5.34e-05	0.000279	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	5.33e-05	0.000807	CbGpPWpGaD
Gemcitabine—Headache—Cyclosporine—psoriasis	5.32e-05	0.000279	CcSEcCtD
Gemcitabine—Anaemia—Methotrexate—psoriasis	5.31e-05	0.000278	CcSEcCtD
Gemcitabine—Feeling abnormal—Betamethasone—psoriasis	5.31e-05	0.000278	CcSEcCtD
Gemcitabine—Feeling abnormal—Dexamethasone—psoriasis	5.31e-05	0.000278	CcSEcCtD
Gemcitabine—POLA1—Cell Cycle, Mitotic—PCNA—psoriasis	5.31e-05	0.000802	CbGpPWpGaD
Gemcitabine—TYMS—Budesonide—Beclomethasone—psoriasis	5.27e-05	0.0108	CbGdCrCtD
Gemcitabine—TYMS—Budesonide—Fluocinonide—psoriasis	5.27e-05	0.0108	CbGdCrCtD
Gemcitabine—Vomiting—Mycophenolate mofetil—psoriasis	5.27e-05	0.000276	CcSEcCtD
Gemcitabine—DCK—Metabolism—CARM1—psoriasis	5.25e-05	0.000795	CbGpPWpGaD
Gemcitabine—Rash—Mycophenolate mofetil—psoriasis	5.22e-05	0.000274	CcSEcCtD
Gemcitabine—Dermatitis—Mycophenolate mofetil—psoriasis	5.22e-05	0.000273	CcSEcCtD
Gemcitabine—Headache—Mycophenolate mofetil—psoriasis	5.19e-05	0.000272	CcSEcCtD
Gemcitabine—Malaise—Methotrexate—psoriasis	5.19e-05	0.000272	CcSEcCtD
Gemcitabine—Diarrhoea—Hydrocortisone—psoriasis	5.16e-05	0.00027	CcSEcCtD
Gemcitabine—Leukopenia—Methotrexate—psoriasis	5.15e-05	0.00027	CcSEcCtD
Gemcitabine—TYMS—Budesonide—Fluocinolone Acetonide—psoriasis	5.12e-05	0.0105	CbGdCrCtD
Gemcitabine—Musculoskeletal discomfort—Prednisone—psoriasis	5.12e-05	0.000268	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	5.11e-05	0.000773	CbGpPWpGaD
Gemcitabine—Asthenia—Triamcinolone—psoriasis	5.1e-05	0.000267	CcSEcCtD
Gemcitabine—Body temperature increased—Betamethasone—psoriasis	5.1e-05	0.000267	CcSEcCtD
Gemcitabine—Body temperature increased—Dexamethasone—psoriasis	5.1e-05	0.000267	CcSEcCtD
Gemcitabine—TYMS—Cell Cycle, Mitotic—PCNA—psoriasis	5.08e-05	0.000769	CbGpPWpGaD
Gemcitabine—Insomnia—Prednisone—psoriasis	5.08e-05	0.000266	CcSEcCtD
Gemcitabine—Nausea—Cyclosporine—psoriasis	5.04e-05	0.000264	CcSEcCtD
Gemcitabine—Paraesthesia—Prednisone—psoriasis	5.04e-05	0.000264	CcSEcCtD
Gemcitabine—Pruritus—Triamcinolone—psoriasis	5.03e-05	0.000263	CcSEcCtD
Gemcitabine—Cough—Methotrexate—psoriasis	5.02e-05	0.000263	CcSEcCtD
Gemcitabine—Nausea—Mycophenolate mofetil—psoriasis	4.92e-05	0.000258	CcSEcCtD
Gemcitabine—Arthralgia—Methotrexate—psoriasis	4.9e-05	0.000256	CcSEcCtD
Gemcitabine—Myalgia—Methotrexate—psoriasis	4.9e-05	0.000256	CcSEcCtD
Gemcitabine—Chest pain—Methotrexate—psoriasis	4.9e-05	0.000256	CcSEcCtD
Gemcitabine—Decreased appetite—Prednisone—psoriasis	4.88e-05	0.000256	CcSEcCtD
Gemcitabine—Rash—Prednisolone—psoriasis	4.87e-05	0.000255	CcSEcCtD
Gemcitabine—Dermatitis—Prednisolone—psoriasis	4.87e-05	0.000255	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	4.86e-05	0.000255	CcSEcCtD
Gemcitabine—Fatigue—Prednisone—psoriasis	4.84e-05	0.000254	CcSEcCtD
Gemcitabine—Headache—Prednisolone—psoriasis	4.84e-05	0.000254	CcSEcCtD
Gemcitabine—Discomfort—Methotrexate—psoriasis	4.84e-05	0.000253	CcSEcCtD
Gemcitabine—Constipation—Prednisone—psoriasis	4.8e-05	0.000252	CcSEcCtD
Gemcitabine—Vomiting—Hydrocortisone—psoriasis	4.8e-05	0.000251	CcSEcCtD
Gemcitabine—Rash—Hydrocortisone—psoriasis	4.76e-05	0.000249	CcSEcCtD
Gemcitabine—Dermatitis—Hydrocortisone—psoriasis	4.75e-05	0.000249	CcSEcCtD
Gemcitabine—POLA1—Cell Cycle—PCNA—psoriasis	4.75e-05	0.000717	CbGpPWpGaD
Gemcitabine—Headache—Hydrocortisone—psoriasis	4.73e-05	0.000248	CcSEcCtD
Gemcitabine—Anaphylactic shock—Methotrexate—psoriasis	4.69e-05	0.000246	CcSEcCtD
Gemcitabine—Infection—Methotrexate—psoriasis	4.66e-05	0.000244	CcSEcCtD
Gemcitabine—Feeling abnormal—Prednisone—psoriasis	4.63e-05	0.000242	CcSEcCtD
Gemcitabine—Asthenia—Dexamethasone—psoriasis	4.63e-05	0.000242	CcSEcCtD
Gemcitabine—Asthenia—Betamethasone—psoriasis	4.63e-05	0.000242	CcSEcCtD
Gemcitabine—Nervous system disorder—Methotrexate—psoriasis	4.6e-05	0.000241	CcSEcCtD
Gemcitabine—Thrombocytopenia—Methotrexate—psoriasis	4.59e-05	0.000241	CcSEcCtD
Gemcitabine—Nausea—Prednisolone—psoriasis	4.59e-05	0.00024	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	4.57e-05	0.000691	CbGpPWpGaD
Gemcitabine—Pruritus—Dexamethasone—psoriasis	4.56e-05	0.000239	CcSEcCtD
Gemcitabine—Pruritus—Betamethasone—psoriasis	4.56e-05	0.000239	CcSEcCtD
Gemcitabine—Skin disorder—Methotrexate—psoriasis	4.56e-05	0.000239	CcSEcCtD
Gemcitabine—TYMS—Cell Cycle—PCNA—psoriasis	4.55e-05	0.000687	CbGpPWpGaD
Gemcitabine—Hyperhidrosis—Methotrexate—psoriasis	4.54e-05	0.000238	CcSEcCtD
Gemcitabine—Vomiting—Triamcinolone—psoriasis	4.52e-05	0.000237	CcSEcCtD
Gemcitabine—Nausea—Hydrocortisone—psoriasis	4.48e-05	0.000235	CcSEcCtD
Gemcitabine—Rash—Triamcinolone—psoriasis	4.48e-05	0.000235	CcSEcCtD
Gemcitabine—Dermatitis—Triamcinolone—psoriasis	4.48e-05	0.000234	CcSEcCtD
Gemcitabine—Anorexia—Methotrexate—psoriasis	4.47e-05	0.000234	CcSEcCtD
Gemcitabine—Headache—Triamcinolone—psoriasis	4.45e-05	0.000233	CcSEcCtD
Gemcitabine—Body temperature increased—Prednisone—psoriasis	4.44e-05	0.000233	CcSEcCtD
Gemcitabine—Diarrhoea—Betamethasone—psoriasis	4.41e-05	0.000231	CcSEcCtD
Gemcitabine—Diarrhoea—Dexamethasone—psoriasis	4.41e-05	0.000231	CcSEcCtD
Gemcitabine—Hypotension—Methotrexate—psoriasis	4.39e-05	0.00023	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	4.38e-05	0.000662	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—APOE—psoriasis	4.31e-05	0.000651	CbGpPWpGaD
Gemcitabine—Musculoskeletal discomfort—Methotrexate—psoriasis	4.28e-05	0.000224	CcSEcCtD
Gemcitabine—Insomnia—Methotrexate—psoriasis	4.24e-05	0.000222	CcSEcCtD
Gemcitabine—ABCB1—Allograft Rejection—IFNG—psoriasis	4.23e-05	0.00064	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	4.22e-05	0.000639	CbGpPWpGaD
Gemcitabine—Nausea—Triamcinolone—psoriasis	4.22e-05	0.000221	CcSEcCtD
Gemcitabine—Paraesthesia—Methotrexate—psoriasis	4.21e-05	0.000221	CcSEcCtD
Gemcitabine—RRM1—Metabolism—CAT—psoriasis	4.2e-05	0.000635	CbGpPWpGaD
Gemcitabine—Dyspnoea—Methotrexate—psoriasis	4.18e-05	0.000219	CcSEcCtD
Gemcitabine—Somnolence—Methotrexate—psoriasis	4.17e-05	0.000219	CcSEcCtD
Gemcitabine—Vomiting—Dexamethasone—psoriasis	4.1e-05	0.000215	CcSEcCtD
Gemcitabine—Vomiting—Betamethasone—psoriasis	4.1e-05	0.000215	CcSEcCtD
Gemcitabine—Decreased appetite—Methotrexate—psoriasis	4.08e-05	0.000214	CcSEcCtD
Gemcitabine—Rash—Betamethasone—psoriasis	4.07e-05	0.000213	CcSEcCtD
Gemcitabine—Rash—Dexamethasone—psoriasis	4.07e-05	0.000213	CcSEcCtD
Gemcitabine—Dermatitis—Dexamethasone—psoriasis	4.06e-05	0.000213	CcSEcCtD
Gemcitabine—Dermatitis—Betamethasone—psoriasis	4.06e-05	0.000213	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Methotrexate—psoriasis	4.05e-05	0.000212	CcSEcCtD
Gemcitabine—Fatigue—Methotrexate—psoriasis	4.05e-05	0.000212	CcSEcCtD
Gemcitabine—Headache—Betamethasone—psoriasis	4.04e-05	0.000212	CcSEcCtD
Gemcitabine—Headache—Dexamethasone—psoriasis	4.04e-05	0.000212	CcSEcCtD
Gemcitabine—DCK—Desoximetasone—Hydrocortisone—psoriasis	4.04e-05	0.00824	CbGdCrCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	4.03e-05	0.000609	CbGpPWpGaD
Gemcitabine—Asthenia—Prednisone—psoriasis	4.03e-05	0.000211	CcSEcCtD
Gemcitabine—Pain—Methotrexate—psoriasis	4.01e-05	0.00021	CcSEcCtD
Gemcitabine—Pruritus—Prednisone—psoriasis	3.97e-05	0.000208	CcSEcCtD
Gemcitabine—ABCB1—Allograft Rejection—CXCL8—psoriasis	3.93e-05	0.000595	CbGpPWpGaD
Gemcitabine—Feeling abnormal—Methotrexate—psoriasis	3.87e-05	0.000203	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	3.86e-05	0.000584	CbGpPWpGaD
Gemcitabine—Diarrhoea—Prednisone—psoriasis	3.84e-05	0.000201	CcSEcCtD
Gemcitabine—Nausea—Dexamethasone—psoriasis	3.83e-05	0.000201	CcSEcCtD
Gemcitabine—Nausea—Betamethasone—psoriasis	3.83e-05	0.000201	CcSEcCtD
Gemcitabine—CDA—Metabolism—PPARG—psoriasis	3.75e-05	0.000567	CbGpPWpGaD
Gemcitabine—DCK—Desoximetasone—Dexamethasone—psoriasis	3.75e-05	0.00765	CbGdCrCtD
Gemcitabine—DCK—Desoximetasone—Betamethasone—psoriasis	3.75e-05	0.00765	CbGdCrCtD
Gemcitabine—Body temperature increased—Methotrexate—psoriasis	3.71e-05	0.000194	CcSEcCtD
Gemcitabine—TYMS—Circadian rythm related genes—TP53—psoriasis	3.71e-05	0.000561	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	3.69e-05	0.000558	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CARM1—psoriasis	3.68e-05	0.000557	CbGpPWpGaD
Gemcitabine—DCK—Desoximetasone—Triamcinolone—psoriasis	3.66e-05	0.00748	CbGdCrCtD
Gemcitabine—DCK—Diflorasone—Dexamethasone—psoriasis	3.64e-05	0.00743	CbGdCrCtD
Gemcitabine—DCK—Diflorasone—Betamethasone—psoriasis	3.64e-05	0.00743	CbGdCrCtD
Gemcitabine—Vomiting—Prednisone—psoriasis	3.57e-05	0.000187	CcSEcCtD
Gemcitabine—DCK—Diflorasone—Triamcinolone—psoriasis	3.55e-05	0.00726	CbGdCrCtD
Gemcitabine—Rash—Prednisone—psoriasis	3.54e-05	0.000185	CcSEcCtD
Gemcitabine—Dermatitis—Prednisone—psoriasis	3.54e-05	0.000185	CcSEcCtD
Gemcitabine—Headache—Prednisone—psoriasis	3.52e-05	0.000184	CcSEcCtD
Gemcitabine—DCK—Desoximetasone—Prednisone—psoriasis	3.48e-05	0.0071	CbGdCrCtD
Gemcitabine—RRM2—Metabolism—CAT—psoriasis	3.46e-05	0.000523	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CAT—psoriasis	3.44e-05	0.00052	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—IL6—psoriasis	3.39e-05	0.000513	CbGpPWpGaD
Gemcitabine—DCK—Desoximetasone—Prednisolone—psoriasis	3.39e-05	0.00693	CbGdCrCtD
Gemcitabine—DCK—Diflorasone—Prednisone—psoriasis	3.37e-05	0.00689	CbGdCrCtD
Gemcitabine—Asthenia—Methotrexate—psoriasis	3.37e-05	0.000176	CcSEcCtD
Gemcitabine—Nausea—Prednisone—psoriasis	3.34e-05	0.000175	CcSEcCtD
Gemcitabine—Pruritus—Methotrexate—psoriasis	3.32e-05	0.000174	CcSEcCtD
Gemcitabine—DCK—Diflorasone—Prednisolone—psoriasis	3.29e-05	0.00672	CbGdCrCtD
Gemcitabine—RRM1—Metabolism—APOE—psoriasis	3.26e-05	0.000493	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	3.24e-05	0.00049	CbGpPWpGaD
Gemcitabine—TYMS—Flunisolide—Hydrocortisone—psoriasis	3.23e-05	0.0066	CbGdCrCtD
Gemcitabine—DCK—Metabolism—CAT—psoriasis	3.23e-05	0.000489	CbGpPWpGaD
Gemcitabine—Diarrhoea—Methotrexate—psoriasis	3.21e-05	0.000168	CcSEcCtD
Gemcitabine—TYMS—Triamcinolone—Hydrocortisone—psoriasis	3.2e-05	0.00653	CbGdCrCtD
Gemcitabine—ABCB1—Allograft Rejection—VEGFA—psoriasis	3.2e-05	0.000483	CbGpPWpGaD
Gemcitabine—TYMS—Clobetasol propionate—Dexamethasone—psoriasis	3.04e-05	0.00621	CbGdCrCtD
Gemcitabine—TYMS—Clobetasol propionate—Betamethasone—psoriasis	3.04e-05	0.00621	CbGdCrCtD
Gemcitabine—TYMS—Flunisolide—Betamethasone—psoriasis	3e-05	0.00613	CbGdCrCtD
Gemcitabine—TYMS—Flunisolide—Dexamethasone—psoriasis	3e-05	0.00613	CbGdCrCtD
Gemcitabine—Vomiting—Methotrexate—psoriasis	2.98e-05	0.000156	CcSEcCtD
Gemcitabine—TYMS—Clobetasol propionate—Triamcinolone—psoriasis	2.97e-05	0.00607	CbGdCrCtD
Gemcitabine—TYMS—Triamcinolone—Betamethasone—psoriasis	2.97e-05	0.00607	CbGdCrCtD
Gemcitabine—TYMS—Triamcinolone—Dexamethasone—psoriasis	2.97e-05	0.00607	CbGdCrCtD
Gemcitabine—Rash—Methotrexate—psoriasis	2.96e-05	0.000155	CcSEcCtD
Gemcitabine—Dermatitis—Methotrexate—psoriasis	2.96e-05	0.000155	CcSEcCtD
Gemcitabine—Headache—Methotrexate—psoriasis	2.94e-05	0.000154	CcSEcCtD
Gemcitabine—TYMS—Flunisolide—Triamcinolone—psoriasis	2.93e-05	0.00599	CbGdCrCtD
Gemcitabine—TYMS—Fluticasone Propionate—Dexamethasone—psoriasis	2.9e-05	0.00592	CbGdCrCtD
Gemcitabine—TYMS—Fluticasone Propionate—Betamethasone—psoriasis	2.9e-05	0.00592	CbGdCrCtD
Gemcitabine—RRM1—Metabolism—PPARG—psoriasis	2.84e-05	0.00043	CbGpPWpGaD
Gemcitabine—TYMS—Fluticasone Propionate—Triamcinolone—psoriasis	2.83e-05	0.00578	CbGdCrCtD
Gemcitabine—TYMS—Clobetasol propionate—Prednisone—psoriasis	2.82e-05	0.00576	CbGdCrCtD
Gemcitabine—Nausea—Methotrexate—psoriasis	2.79e-05	0.000146	CcSEcCtD
Gemcitabine—TYMS—Flunisolide—Prednisone—psoriasis	2.78e-05	0.00568	CbGdCrCtD
Gemcitabine—TYMS—Triamcinolone—Prednisone—psoriasis	2.76e-05	0.00563	CbGdCrCtD
Gemcitabine—TYMS—Clobetasol propionate—Prednisolone—psoriasis	2.75e-05	0.00562	CbGdCrCtD
Gemcitabine—ABCB1—Allograft Rejection—TNF—psoriasis	2.74e-05	0.000414	CbGpPWpGaD
Gemcitabine—TYMS—Diflorasone—Dexamethasone—psoriasis	2.74e-05	0.00559	CbGdCrCtD
Gemcitabine—TYMS—Diflorasone—Betamethasone—psoriasis	2.74e-05	0.00559	CbGdCrCtD
Gemcitabine—ABCB1—Metabolism—NDUFA5—psoriasis	2.74e-05	0.000414	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.72e-05	0.000412	CbGpPWpGaD
Gemcitabine—TYMS—Flunisolide—Prednisolone—psoriasis	2.72e-05	0.00555	CbGdCrCtD
Gemcitabine—TYMS—Triamcinolone—Prednisolone—psoriasis	2.69e-05	0.00549	CbGdCrCtD
Gemcitabine—RRM2—Metabolism—APOE—psoriasis	2.69e-05	0.000406	CbGpPWpGaD
Gemcitabine—TYMS—Diflorasone—Triamcinolone—psoriasis	2.68e-05	0.00546	CbGdCrCtD
Gemcitabine—POLD1—Metabolism—APOE—psoriasis	2.67e-05	0.000404	CbGpPWpGaD
Gemcitabine—TYMS—Budesonide—Hydrocortisone—psoriasis	2.59e-05	0.00528	CbGdCrCtD
Gemcitabine—RRM2—Cell Cycle—TP53—psoriasis	2.55e-05	0.000386	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	2.54e-05	0.000385	CbGpPWpGaD
Gemcitabine—TYMS—Diflorasone—Prednisone—psoriasis	2.54e-05	0.00519	CbGdCrCtD
Gemcitabine—POLD1—Cell Cycle—TP53—psoriasis	2.54e-05	0.000383	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—APOE—psoriasis	2.51e-05	0.00038	CbGpPWpGaD
Gemcitabine—TYMS—Diflorasone—Prednisolone—psoriasis	2.48e-05	0.00506	CbGdCrCtD
Gemcitabine—TYMS—Danazol—Hydrocortisone—psoriasis	2.48e-05	0.00506	CbGdCrCtD
Gemcitabine—POLE—Cell Cycle—TP53—psoriasis	2.45e-05	0.00037	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	2.43e-05	0.000367	CbGpPWpGaD
Gemcitabine—TYMS—Budesonide—Betamethasone—psoriasis	2.4e-05	0.0049	CbGdCrCtD
Gemcitabine—TYMS—Budesonide—Dexamethasone—psoriasis	2.4e-05	0.0049	CbGdCrCtD
Gemcitabine—DCK—Levonorgestrel—Hydrocortisone—psoriasis	2.36e-05	0.00482	CbGdCrCtD
Gemcitabine—TYMS—Budesonide—Triamcinolone—psoriasis	2.35e-05	0.00479	CbGdCrCtD
Gemcitabine—RRM2—Metabolism—PPARG—psoriasis	2.34e-05	0.000354	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP2S1—psoriasis	2.33e-05	0.000352	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PPARG—psoriasis	2.33e-05	0.000352	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CAT—psoriasis	2.27e-05	0.000343	CbGpPWpGaD
Gemcitabine—TYMS—Budesonide—Prednisone—psoriasis	2.23e-05	0.00455	CbGdCrCtD
Gemcitabine—DCK—Metabolism—PPARG—psoriasis	2.19e-05	0.000331	CbGpPWpGaD
Gemcitabine—TYMS—Budesonide—Prednisolone—psoriasis	2.17e-05	0.00444	CbGdCrCtD
Gemcitabine—TYMS—Danazol—Prednisone—psoriasis	2.13e-05	0.00436	CbGdCrCtD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.81e-05	0.000273	CbGpPWpGaD
Gemcitabine—TYMS—Levonorgestrel—Hydrocortisone—psoriasis	1.78e-05	0.00363	CbGdCrCtD
Gemcitabine—TYMS—Metabolism—APOE—psoriasis	1.76e-05	0.000266	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—TP53—psoriasis	1.74e-05	0.000264	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.74e-05	0.000263	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—TP53—psoriasis	1.67e-05	0.000253	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.58e-05	0.000238	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PPARG—psoriasis	1.53e-05	0.000232	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.35e-05	0.000204	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.19e-05	0.00018	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CARM1—psoriasis	1.14e-05	0.000172	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CAT—psoriasis	6.99e-06	0.000106	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—APOE—psoriasis	5.43e-06	8.22e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PPARG—psoriasis	4.73e-06	7.16e-05	CbGpPWpGaD
